Fond pour text


Lasting remission is the ultimate therapeutic objective in the treatment of rheumatoid arthritis.

Progress made in the therapeutic care of rheumatoid arthritis now means that the disease can be controlled more effectively and it is possible to consider a sustainable remission.

To assist the doctor and the patient in achieving the ultimate goal of disease remission, mYXpression has developed RITI® RA, a test that identifies the most efficient biologic therapy for the patient based on their biology.

RITI® RA provides the patient and their doctor with access to a personalized analysis report. This report delivers an efficacy score for each biologic therapy.

The RITI® RA test offers real precision medicine and is a valuable aid in optimizing the therapeutic strategy to adopt:

“The right treatment, for the right patient at the right time."

RITI® RA is currently undergoing clinical trials and will be available by 2025.

Find out more